These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12428717)

  • 1. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses.
    Trojanowski JQ; Lee VM
    Neurotoxicology; 2002 Oct; 23(4-5):457-60. PubMed ID: 12428717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain.
    Trojanowski JQ; Lee VM
    Parkinsonism Relat Disord; 2001 Jul; 7(3):247-251. PubMed ID: 11331194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
    Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
    Neuropharmacology; 2003 Jul; 45(1):14-44. PubMed ID: 12814657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R; Müller T; Riess O
    J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell biology of alpha-synuclein: a sticky problem?
    Cole NB; Murphy DD
    Neuromolecular Med; 2002; 1(2):95-109. PubMed ID: 12025860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotenone neurotoxicity: a new window on environmental causes of Parkinson's disease and related brain amyloidoses.
    Trojanowski JQ
    Exp Neurol; 2003 Jan; 179(1):6-8. PubMed ID: 12504862
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses.
    Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 2003 Jun; 991():107-10. PubMed ID: 12846979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein.
    Masliah E; Hashimoto M
    Neurotoxicology; 2002 Oct; 23(4-5):461-8. PubMed ID: 12428718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synucleinopathies: clinical and pathological implications.
    Galvin JE; Lee VM; Trojanowski JQ
    Arch Neurol; 2001 Feb; 58(2):186-90. PubMed ID: 11176955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein: between synaptic function and dysfunction.
    Di Rosa G; Puzzo D; Sant'Angelo A; Trinchese F; Arancio O
    Histol Histopathol; 2003 Oct; 18(4):1257-66. PubMed ID: 12973692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH; Giasson BI; Lee VM
    Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease and other alpha-synucleinopathies.
    Goedert M
    Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
    Hegde ML; Jagannatha Rao KS
    Arch Biochem Biophys; 2003 Oct; 418(2):169-78. PubMed ID: 14522588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant Parkinson's disease and alpha-synuclein.
    Polymeropoulos MH
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S63-4. PubMed ID: 9749575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.